| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 11/30/2006 | CA2608835A1 Pretreatment of a biological sample from an autoimmune disease subject |
| 11/30/2006 | CA2608522A1 Biomarkers for breast cancer |
| 11/30/2006 | CA2608306A1 Annexin for cancer risk assessment |
| 11/30/2006 | CA2607852A1 Transgenic alzheimer's mouse model vectors and uses thereof |
| 11/30/2006 | CA2578227A1 Epoxy enhanced polymer membrane to increase durability of biosensors |
| 11/29/2006 | EP1726962A1 Apolipoprotein E plasma levels for monitoring and reducing the risk of cardiovascular disease |
| 11/29/2006 | EP1726961A1 Agent and method for examining infection with adult taeniasis solium and taeniarhynchus saginatus |
| 11/29/2006 | EP1726960A1 Means and methods for the detection of anti-Borrelia-antibodies and kit for the use in the diagnosis of Lyme-Borrelia infections |
| 11/29/2006 | EP1726959A2 Light-controlled electrokinetic Assembly of particles near surfaces |
| 11/29/2006 | EP1726958A2 Light-controlled electrokinetic assembly of particles near surfaces |
| 11/29/2006 | EP1726957A2 Light-controlled electrokinetic assembly of particles near surfaces |
| 11/29/2006 | EP1726956A1 Diagnostic sensor |
| 11/29/2006 | EP1726955A1 Method of stabilizing oxidizable color-assuming reagent |
| 11/29/2006 | EP1726954A2 Methods of screening for modulators of cell proliferation and methods of diagnosing cell proliferation states |
| 11/29/2006 | EP1726953A1 Biomarker for response monitoring of CDK inhibitors in the clinic |
| 11/29/2006 | EP1726952A1 Method of in vivo screening of therapeutic agent for memory/learning dysfunction by schizophrenia |
| 11/29/2006 | EP1726951A1 Cartridge for storing test elements |
| 11/29/2006 | EP1726950A1 Cartridge for storing test elements |
| 11/29/2006 | EP1726949A1 Oil change determination with identification of the lubricating oil in the machine |
| 11/29/2006 | EP1726939A2 Molecular interaction detector and molecule recovery device using the same |
| 11/29/2006 | EP1726663A1 Method of detecting gene mutation and kit for detecting gene mutation |
| 11/29/2006 | EP1726660A1 Method of measuring glycoprotein |
| 11/29/2006 | EP1726649A2 Peptide fragment having cytotoxicity-inhibitory activity and screening method for peptide fragment having said cytotoxicity-inhibitory activity |
| 11/29/2006 | EP1726646A1 Method of detecting carcinogenesis caused by hepatitis b virus |
| 11/29/2006 | EP1726640A1 Rat embryonic stem cell |
| 11/29/2006 | EP1726596A1 Sugar chain ligand composite and method of analyzing protein with the ligand composite |
| 11/29/2006 | EP1726563A1 Method for sensing the type of fuel of vehicles at a filling station |
| 11/29/2006 | EP1726313A1 Drug for preventing and treating arteriosclerosis |
| 11/29/2006 | EP1726258A2 Exhaled-air filter, collecting apparatus, analyzing system and method |
| 11/29/2006 | EP1726075A2 Environmental fuse |
| 11/29/2006 | EP1725968A1 Method and apparatus for chemometric estimations of fluid density, viscosity, dielectric constant, and resistivity from mechanical resonator data |
| 11/29/2006 | EP1725967A2 Methods for genetic analysis |
| 11/29/2006 | EP1725915A1 Process control system |
| 11/29/2006 | EP1725881A2 Test element analysis system with contact surfaces coated with hard material |
| 11/29/2006 | EP1725876A1 A method for predicting the state of the gastric mucosa |
| 11/29/2006 | EP1725875A1 Methods for identifying compounds capable of modulating the hydrolase activity of clca protien |
| 11/29/2006 | EP1725874A2 Prion immunoassay and separation method |
| 11/29/2006 | EP1725873A1 Pharmacodynamic assays using flow cytometry. |
| 11/29/2006 | EP1725872A2 Analysis of saccharide vaccines without interference |
| 11/29/2006 | EP1725871A1 Separation of unconjugated and conjugated saccharide by solid phase extraction |
| 11/29/2006 | EP1725870A1 Anti-lipid rafts antibodies |
| 11/29/2006 | EP1725869A1 Man2as as modifiers of the iger pathway and methods of use |
| 11/29/2006 | EP1725868A2 Methods of using high affinity atiii variants |
| 11/29/2006 | EP1725867A1 Analysis element for use in method of testing specimen |
| 11/29/2006 | EP1725866A1 Assay chip |
| 11/29/2006 | EP1725865A1 Spectrophotometric analysis of plasma in a closed-container |
| 11/29/2006 | EP1725861A1 Liquid electrolyte gas sensor comprising rigid porous electrode support |
| 11/29/2006 | EP1725859A2 Heath monitoring method and apparatus for composite materials |
| 11/29/2006 | EP1725855A1 Recognition chip for target substance, and detection method and device for the same |
| 11/29/2006 | EP1725854A1 Method for imaging and differential analysis of cells |
| 11/29/2006 | EP1725844A1 Instruments, related systems, and methods for monitoring or controlling foaming |
| 11/29/2006 | EP1725687A2 Hsv-2 type-specific immunoassays using glycoprotein g2 peptides |
| 11/29/2006 | EP1725678A1 Differential drug sensitivity |
| 11/29/2006 | EP1725673A1 Sialytated glycoproteins-process conditions and an efficient method for their production |
| 11/29/2006 | EP1725662A1 Infectious aetiology of prostatic disease and methods to identify causative agents |
| 11/29/2006 | EP1725657A1 Prostatic acid phosphatase antigens |
| 11/29/2006 | EP1725655A2 Prostate stem cell |
| 11/29/2006 | EP1725651A2 Cell concentration and pathogen recovery |
| 11/29/2006 | EP1725650A2 Reagent combination and method for direct test strip measurement of cholesterol from low density lipoproteins at ambient temperatures |
| 11/29/2006 | EP1725587A2 Compositions and methods for detection of single molecules |
| 11/29/2006 | EP1725581A1 Novel assay for the separation and quantification of hemagglutinin antigens |
| 11/29/2006 | EP1725330A2 Microfluidic chip |
| 11/29/2006 | EP1725270A1 Methods for uniformly treating biological samples with electromagnetic radiation |
| 11/29/2006 | EP1725224A2 Methods and compositions comprising non-peptide small molecules that solubilize beta amyloid peptide fiber |
| 11/29/2006 | EP1725221A2 Use of mrp4-inhibitors for the treatment and/or prophylaxis of cardiovascular diseases |
| 11/29/2006 | EP1725112A2 Cell display libraries |
| 11/29/2006 | EP1725111A2 Methods and compositions for inhibition of metastasis |
| 11/29/2006 | EP1623030B1 Topoisomerase hybrids and methods of use |
| 11/29/2006 | EP1618206A4 Apparatus and method for detecting live cells with an integrated filter and growth detection device |
| 11/29/2006 | EP1613205A4 Erbb surface receptor complexes as biomarkers |
| 11/29/2006 | EP1589928B1 Method and device for testing the breakability and the breaking accuracy of tablets |
| 11/29/2006 | EP1585963A4 Method of evaluating myelosuppressive state |
| 11/29/2006 | EP1581645A4 Method for using division arrested cells in screening assays |
| 11/29/2006 | EP1540015A4 Assays and compositions for identifying agents that modulate the activity of deubiquitinating agents |
| 11/29/2006 | EP1535068A4 Devices and methods for detecting amniotic fluid in vaginal secretions |
| 11/29/2006 | EP1534863A4 Methods and compositions for functional ubiquitin assays |
| 11/29/2006 | EP1532452A4 Heterologous stimulus-gated ion channels and methods of using same |
| 11/29/2006 | EP1497656B1 Diagnosis of carcinoma using raig1 polypeptides |
| 11/29/2006 | EP1495439A4 Assaying and imaging system identifying traits of biological specimens |
| 11/29/2006 | EP1478774A4 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 11/29/2006 | EP1472447B1 Method for operating a gas turbine group |
| 11/29/2006 | EP1468023A4 Binding proteins as biosensors |
| 11/29/2006 | EP1434993A4 Methods of assaying connective tissue growth factor |
| 11/29/2006 | EP1433859B1 Method of determining target protein of drug |
| 11/29/2006 | EP1423708B1 Compositions and methods for aa4rp assay |
| 11/29/2006 | EP1392860A4 Molecular detection chip including mosfet, molecular detection device employing the chip, and molecular detection method using the device |
| 11/29/2006 | EP1390544B1 Universal multi-variant detection system |
| 11/29/2006 | EP1385860B1 Immobilization of oligonucleotides onto solid supports |
| 11/29/2006 | EP1373868A4 Improved affinity matrices with enhanced visibility for molecular pull-down and immunoprecipitation applications |
| 11/29/2006 | EP1373573A4 Conjugate probes and optical detection of analytes |
| 11/29/2006 | EP1356115B1 Methods for detection of chloral hydrate in dichloroacetic acid |
| 11/29/2006 | EP1351762B1 Infrared thermographic screening technique for semiconductor-based chemical sensors |
| 11/29/2006 | EP1313504B1 Methods and compositions for inhibiting angiogenesis |
| 11/29/2006 | EP1299724B1 Synthetic peptide for neurological disorders |
| 11/29/2006 | EP1226539B1 Method and means for data management in a laboratory |
| 11/29/2006 | EP1220911B1 P-glycoproteins and uses thereof |
| 11/29/2006 | EP1206529B1 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-BETA 1,3-N-ACETYLGALACTOSAMINE-ALPHA-R/(GlcNAc to GalNAc) BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
| 11/29/2006 | EP1196598B1 Dsp-3 dual-specificity phosphatase |
| 11/29/2006 | EP1173771B1 Procoagulant assay |
| 11/29/2006 | EP1141026B1 Compositions and methods for generating monoclonal antibodies representative of a specific cell type |